ADAR1 Capital Management »

Anaptysbio Inc Common shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Anaptysbio Inc Common (ANAB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Anaptysbio Inc Common

Tip: Access up to 7 years of quarterly data

All positions including Anaptysbio Inc Common held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anaptysbio Inc Common by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.5M 193k 33.50
2024-06-30 $3.9M 157k 25.06
2024-03-31 $68k 3.0k 22.52

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Anaptysbio Inc Common

EcoR1 Capital
FMR
Frazier Life Sciences Management
BlackRock
Vanguard Group
Tang Capital Management
Boxer Capital
First Light Asset Management
T. Rowe Price Associates
State Street Corporation
Palo Alto Investors
Ikarian Capital
Mangrove Partners
Geode Capital Management
Woodline Partners

View all funds holding Anaptysbio Inc Common